Emcure Pharmaceuticals Reports 36% Profit Rise and 23% Revenue Growth in Q1 FY27
Emcure Pharmaceuticals reported a 36.2% year-on-year rise in consolidated net profit to Rs 292.5 crore for Q1 FY27, with revenue increasing 22.8% to Rs 2,580.45 crore. Domestic revenue grew 10.2% to Rs 1,095.3 crore, while international business rose 34.2% to Rs 1,485.1 crore, accounting for 57.6% of total revenue. EBITDA increased 25.8% to Rs 508 crore, with improved margins. The company invested Rs 90.4 crore in research and development. Leadership changes include Satish Mehta becoming Chairman post-AGM.
First-hand measurement across 8 sources
We measured how 8 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (70/100). Lens Score 34/100.
Outlets measured: economictimes, economictimes, businessstandard, news18, thetribune, businessstandard, news18, freepressjournal. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (58–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
freepressjournal broke this story on 6 Aug, 08:49 am. Other outlets followed.